Centre Hospitalier Universitaire Amiens Picardie

The medical center is at the forefront of research in hematological disorders, focusing on innovative treatments for conditions such as Primary Myelofibrosis, Chronic Lymphocytic Leukemia, and Acute Myeloid Leukemia. The center's research aims to improve patient outcomes through novel therapeutic approaches and personalized medicine.

• Primary Myelofibrosis
• Chronic Lymphocytic Leukemia
• Acute Myeloid Leukemia

By integrating cutting-edge research with clinical practice, the center is advancing the understanding and treatment of complex blood disorders.

Specializing in gastroenterology, the center conducts pioneering research on Crohn's Disease and Ulcerative Colitis. The focus is on developing therapies that promote transmural healing and improve long-term patient outcomes.

• Crohn's Disease
• Ulcerative Colitis

Through innovative clinical trials, the center is enhancing therapeutic strategies and contributing to the global understanding of inflammatory bowel diseases.

The center is a leader in oncology research, with a focus on Multiple Myeloma, Melanoma, and Breast Cancer. By exploring novel drug combinations and treatment protocols, the center aims to improve survival rates and quality of life for cancer patients.

• Multiple Myeloma
• Melanoma
• Breast Cancer

Through collaborative research efforts, the center is at the forefront of developing new cancer therapies and advancing precision medicine.

In the fields of cardiology and nephrology, the center is investigating treatments for Acute Kidney Injury and Hyponatremia. The research focuses on improving cardiovascular outcomes and managing electrolyte imbalances in critical care settings.

• Acute Kidney Injury
• Hyponatremia

By integrating clinical research with patient care, the center is enhancing therapeutic approaches for complex cardiovascular and renal conditions.

The center is advancing research in neurology and autoimmune diseases, focusing on conditions such as Parkinson's Disease and Rheumatoid Arthritis. The goal is to develop therapies that improve neurological function and manage autoimmune responses.

• Parkinson's Disease
• Rheumatoid Arthritis

Through innovative research and clinical trials, the center is contributing to the development of new treatments that enhance patient quality of life.